Arcutis Biotherapeutics Inc (ARQT)

Finanzdaten der Arcutis Biotherapeutics Inc-Aktie (ARQT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.21%129.86	105.40	129.50	99.22	81.50
Cost Of Revenue	11.80%10.94	9.78	11.69	8.69	7.49
	10.88%82.14	74.08	-	-	-
Selling, General, and Administrative	10.88%82.14	74.08	-	-	-
Research and Development	33.54%20.36	30.63	-	-	-
Costs And Expenses	0.92%113.43	114.49	111.12	90.69	96.12
Operating Income/Loss	280.76%16.43	-9.09	18.39	8.53	-14.61
Nonoperating Income/Loss	-1.28	-	-	-	-
Income Tax Expense/Benefit	46.24%0.14	0.09	0.47	0.08	0.34
	232.88%15.01	-11.30	17.40	7.41	-15.89
Attributable To Parent	232.88%15.01	-11.30	17.40	7.41	-15.89
Basic Average Shares	100.79K%130.52	0.13	0.34	127.62	127.00
Diluted Average Shares	104.95K%135.90	0.13	0.34	132.88	127.00
Basic Earnings Per Share	222.22%0.11	-0.09	0.13	0.06	-0.13
Diluted Earnings Per Share	222.22%0.11	-0.09	0.13	0.06	-0.13